Total Payments
$6,859
2023 Payments
$83.57
Companies
31
Transactions
396
Medicare Patients
473
Medicare Billing
$59,705
Payment Breakdown by Category
Food & Beverage$6,806 (99.2%)
Education$52.78 (0.8%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $6,806 | 393 | 99.2% |
| Education | $52.78 | 3 | 0.8% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Sunovion Pharmaceuticals Inc. | $1,322 | 77 | $0 (2022) |
| ABBVIE INC. | $833.56 | 44 | $0 (2022) |
| Otsuka America Pharmaceutical, Inc. | $679.84 | 44 | $0 (2022) |
| Alkermes, Inc. | $550.31 | 31 | $0 (2022) |
| Allergan, Inc. | $507.17 | 38 | $0 (2020) |
| Neurocrine Biosciences, Inc. | $414.43 | 27 | $0 (2022) |
| Lundbeck LLC | $324.04 | 17 | $0 (2022) |
| Shire North American Group Inc | $264.35 | 15 | $0 (2019) |
| Janssen Pharmaceuticals, Inc | $243.28 | 14 | $0 (2022) |
| Vanda Pharmaceuticals Inc. | $241.30 | 9 | $0 (2022) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2023 | $83.57 | 4 | ITI, Inc. ($29.80) |
| 2022 | $891.59 | 46 | ABBVIE INC. ($331.27) |
| 2021 | $1,311 | 64 | AbbVie Inc. ($502.29) |
| 2020 | $1,030 | 53 | Sunovion Pharmaceuticals Inc. ($242.53) |
| 2019 | $943.10 | 61 | Sunovion Pharmaceuticals Inc. ($207.19) |
| 2018 | $1,143 | 76 | Allergan Inc. ($237.03) |
| 2017 | $1,457 | 92 | Sunovion Pharmaceuticals Inc. ($386.21) |
All Payment Transactions
396 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 03/15/2023 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $17.31 | General |
| Category: Central Nervous System | ||||||
| 02/28/2023 | Supernus Pharmaceuticals, Inc. | QELBREE (Drug) | Food and Beverage | Cash or cash equivalent | $14.62 | General |
| Category: PSYCHOLOGY | ||||||
| 01/11/2023 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $21.84 | General |
| Category: NEUROSCIENCE | ||||||
| 01/03/2023 | ITI, Inc. | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $29.80 | General |
| Category: PSYCHIATRY | ||||||
| 12/07/2022 | Vanda Pharmaceuticals Inc. | HETLIOZ (Drug), FANAPT | Food and Beverage | In-kind items and services | $33.36 | General |
| Category: NON-24-HOUR SLEEP-WAKE DISORDER | ||||||
| 11/09/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $22.86 | General |
| Category: CNS | ||||||
| 11/02/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $26.88 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $23.29 | General |
| Category: CNS | ||||||
| 10/12/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $24.33 | General |
| Category: Neuroscience | ||||||
| 09/14/2022 | Ironshore Pharmaceuticals Inc. | JORNAY PM (Drug) | Food and Beverage | In-kind items and services | $22.24 | General |
| Category: Central Nervous Stimulant ADHD | ||||||
| 08/30/2022 | Otsuka America Pharmaceutical, Inc. | ABILIFY MAINTENA (Drug), REXULTI | Food and Beverage | In-kind items and services | $17.42 | General |
| Category: PSYCHIATRY | ||||||
| 08/24/2022 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $25.80 | General |
| Category: Neuropsychiatry | ||||||
| 08/17/2022 | Corium, LLC | AZSTARYS (Drug) | Food and Beverage | In-kind items and services | $21.31 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/10/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: CNS | ||||||
| 08/03/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $30.51 | General |
| Category: PSYCHIATRY | ||||||
| 07/28/2022 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $16.72 | General |
| Category: Neurology | ||||||
| 07/28/2022 | Sunovion Pharmaceuticals Inc. | LATUDA (Drug) | Food and Beverage | In-kind items and services | $11.50 | General |
| Category: CNS | ||||||
| 07/27/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $23.71 | General |
| Category: NEUROSCIENCE | ||||||
| 07/06/2022 | Teva Pharmaceuticals USA, Inc. | AUSTEDO (Drug) | Food and Beverage | In-kind items and services | $24.24 | General |
| Category: Central Nervous System | ||||||
| 07/06/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $24.00 | General |
| Category: NEUROSCIENCE | ||||||
| 06/29/2022 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $21.09 | General |
| Category: PSYCHIATRY | ||||||
| 06/21/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $10.86 | General |
| Category: NEUROSCIENCE | ||||||
| 06/15/2022 | Janssen Pharmaceuticals, Inc | SPRAVATO (Drug) | Food and Beverage | In-kind items and services | $21.29 | General |
| Category: Neuroscience | ||||||
| 06/15/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $7.52 | General |
| Category: NEUROSCIENCE | ||||||
| 06/08/2022 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $29.86 | General |
| Category: NEUROSCIENCE | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 1 | 21 | 40 | $8,000 | $1,716 |
| 2022 | 2 | 138 | 252 | $27,600 | $14,339 |
| 2021 | 2 | 142 | 354 | $38,050 | $22,165 |
| 2020 | 3 | 172 | 373 | $42,450 | $21,485 |
Total Patients
473
Total Services
1,019
Medicare Billing
$59,705
Procedure Codes
8
All Medicare Procedures & Services
8 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 21 | 40 | $8,000 | $1,716 | 21.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 107 | 204 | $20,400 | $10,406 | 51.0% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 31 | 48 | $7,200 | $3,933 | 54.6% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 119 | 301 | $30,100 | $17,591 | 58.4% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 23 | 53 | $7,950 | $4,574 | 57.5% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 129 | 294 | $29,400 | $15,416 | 52.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 31 | 67 | $10,050 | $5,160 | 51.3% |
| 90792 | Psychiatric diagnostic evaluation with medical services | Office | 2020 | 12 | 12 | $3,000 | $909.16 | 30.3% |
About Dr. Joseph Adan, M.D
Dr. Joseph Adan, M.D is a Psychiatry healthcare provider based in Clearwater, Florida. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/22/2006. The National Provider Identifier (NPI) number assigned to this provider is 1609832203.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Joseph Adan, M.D has received a total of $6,859 in payments from pharmaceutical and medical device companies, with $83.57 received in 2023. These payments were reported across 396 transactions from 31 companies. The most common payment nature is "Food and Beverage" ($6,806).
As a Medicare-enrolled provider, Adan has provided services to 473 Medicare beneficiaries, totaling 1,019 services with total Medicare billing of $59,705. Data is available for 4 years (2020–2023), covering 8 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Clearwater, FL
- Active Since 04/22/2006
- Last Updated 01/27/2022
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1609832203
Products in Payments
- VRAYLAR (Drug) $1,323
- LATUDA (Drug) $1,322
- REXULTI (Drug) $552.55
- INGREZZA (Drug) $414.43
- ABILIFY MAINTENA (Drug) $311.88
- Aristada 441 mg (Drug) $300.67
- ARISTADA (Drug) $249.64
- VYVANSE (Drug) $186.37
- HETLIOZ (Drug) $181.62
- CAPLYTA (Drug) $167.16
- AUSTEDO (Drug) $157.39
- SUNOSI (Drug) $147.50
- TRINTELLIX (Drug) $124.54
- SPRAVATO (Drug) $117.47
- JORNAY PM (Drug) $108.12
- INVEGA SUSTENNA (Drug) $107.41
- Trintellix (Drug) $100.55
- Dyanavel XR (Drug) $97.14
- Adzenys XR-ODT (Drug) $96.35
- Dayvigo (Drug) $82.64
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Clearwater
Dr. Michelle Scargle, Md, MD
Psychiatry — Payments: $592,222
Psychiatry $592,222
Dr. Jana Ramsey-Liao, M.d, M.D
Psychiatry — Payments: $22,905
Psychiatry $22,905
Dr. Joseph Shanklin, Md, MD
Psychiatry — Payments: $9,606
Psychiatry $9,606
Dr. Harshadkumar Patel, M.d, M.D
Psychiatry — Payments: $5,174
Psychiatry $5,174
Dr. Mariko Brandon, M.d, M.D
Psychiatry — Payments: $4,825
Psychiatry $4,825
Vijay Hegde, M.d, M.D
Psychiatry — Payments: $4,390
Psychiatry $4,390